20 January 2026
Aspect Biosystems and Novo Nordisk Advance Partnership for Diabetes Medicines
The partnership focuses on developing cellular therapies for diabetes, integrating technologies, and expanding manufacturing and R&D capabilities across Canada, the US, and Denmark.